70 studies found for:    Open Studies | "Antiretroviral Therapy, Highly Active" OR HAART
Show Display Options
Rank Status Study
21 Recruiting A Study of Selumetinib in Patients With Kaposi's Sarcoma
Condition: AIDS-related Kaposi's Sarcoma
Intervention: Drug: Selumetinib
22 Recruiting Switch to Darunavir/r + Maraviroc Quaque Die in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA)
Condition: HIV Infection
Interventions: Drug: Maraviroc, Darunavir/r;   Drug: current antiretroviral therapy with 3 drugs
23 Unknown  Acquired Immunodeficiency Syndrome(AIDS) and Tuberculosis(Tb) Co-infection Treatment Strategies Study of China.
Condition: AIDS
Intervention: Drug: INH RIF Rifb PZA EMB AZT 3TC D4T EFV
24 Not yet recruiting Prospective HIV Chemotherapy Cohort Study
Conditions: HIV;   Cancer
Intervention: Other: No intervention for this study
25 Unknown  Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT)
Conditions: NVP Plasma Level;   NVP Related Mutation;   3TC Related Mutation
Intervention: Drug: AZT/3TC 2 weeks after delivery
26 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: PEG-IFNa 2a;   Drug: Ribavirin;   Drug: NUCS
27 Recruiting HAART 200 Aortic Valve Annuloplasty During Bicuspid Aortic Valve Reconstruction
Condition: Aortic Insufficiency
Intervention: Device: Bicuspid Aortic Valve Repair
28 Unknown  Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment
Conditions: HIV;   AIDS;   Tuberculosis
Interventions: Drug: Simultaneous ARV and antiMTB;   Drug: Deferred RV and antiMTB treatment
29 Recruiting Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis
Conditions: HIV Infection;   Osteopenia;   Osteoporosis
Intervention:
30 Unknown  Metabolic Safety of Raltegravir Versus Darunavir in HIV Naive Patients
Conditions: Cardiovascular Disease;   HIV Infections
Intervention:
31 Unknown  Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis
Conditions: Acquired Immunodeficiency Syndrome;   Tuberculosis
Intervention: Other: Comparison of different treatment strategies
32 Recruiting Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention
Condition: Reduction in Heavy Drinking in Patients With HIV
Interventions: Drug: Naltrexone;   Other: Placebo + Medication Management/Medication Coaching
33 Recruiting Trends of Morbidity and Mortality Among Thai HIV-infected and HIV-uninfected Patients: a Five-year Prospective Cohort Study
Conditions: HIV Infection;   Healthy
Intervention:
34 Recruiting Management of Highly Active Anti-retroviral Therapy-related Hyperlipidemia Among HIV-infected Patients in Taiwan
Condition: HIV
Intervention:
35 Recruiting Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Biological: HIVAX;   Biological: saline solution;   Biological: Saline solution
36 Recruiting Maraviroc Abacavir STudy - Effect on Endothelial Recovery
Condition: Endothelial Dysfunction
Intervention: Drug: Maraviroc
37 Not yet recruiting Patient Retention in HIV Medical Care in a Primary Care Practice in Australia
Condition: HIV
Intervention:
38 Recruiting Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand
Condition: HIV Infections
Intervention:
39 Recruiting Study to Improve Survival Among HIV-Exposed Infants in Botswana
Conditions: HIV Infections;   Neutropenia;   Anemia
Interventions: Drug: cotrimoxazole prophylaxis;   Drug: cotrimoxazole placebo;   Behavioral: exclusive breastfeeding until 6 months of age;   Behavioral: breastfeeding for 12 months
40 Not yet recruiting Immune Activation and Drug Absorption in HIV-Infected Patients
Condition: HIV Infection
Intervention: Drug: Rifampicin 600 mg

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years